Armata Pharmaceuticals, Inc. Common Stock (ARMP)

This $13M Biotech Has $40M in Pentagon Funding – Here’s Why BiomX Could Be Biotech’s Best-Kept Secret

San Diego, CA -- (SBWIRE) -- 05/20/2021 -- An investigation on behalf of investors in shares of Armata Pharmaceuticals Inc. (NYSE:ARMP) was announced over potential breaches of fiduciary duties by certain officers and directors at Armata Pharmaceuticals Inc. .